|
|
|
cGMP Home
FDA Home | Search FDA Site
| A-Z Index | Contact
FDA
"A Drug Quality System for the 21st Century"
Breakout Session:
Risk-Based cGMPs: Defining Risk and Quality
Click here to start presentation
|
Table of Contents Points to Consider in Defining Risk Definition of Quality in the Context of Mfg & Control of Products Benefits of a Risk Based System |
Author:
Edward Kaminski, PH.D., Wyeth Pharmaceuticals April 24, 2003 |